Navigation Links
Sentinelle Medical Enters OEM Distribution Agreement with Toshiba
Date:11/30/2008

TORONTO, Nov. 30 /PRNewswire/ - Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and software, and Toshiba America Medical Systems, Inc. are announcing an OEM Distribution Agreement for Sentinelle's Vanguard(R) T-Series coil at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 - Dec. 5, 2008. (Sentinelle Booth 6259, Hall A)

Under this agreement, Toshiba will offer the Sentinelle Vanguard(R) T-Series, 1.5T, 8 channel tabletop breast coils for Vantage Atlas(TM) and Vantage Titan(TM), through its North American direct sales channels. Toshiba will be integrating this system into its Radiance Plus Breast Imaging Suite. Access for breast positioning and intervention is optimized with the Sentinelle Vanguard's unique patient support design. Sentinelle's proprietary Variable Coil Geometry(TM) optimizes coil positioning which can result in improved signal-to-noise ratio, significantly increasing the image quality. Exams can also be performed feet first, reducing patient anxiety and claustrophobia.

"Sentinelle's partnership with Toshiba, an innovator in breast MRI, will increase patient accessibility to MRI technology and the early detection of breast cancer", said Cameron Piron, Sentinelle's President and CEO. "Toshiba's commitment to improving the patient experience and ultimately, to delivering better health outcomes through improved imaging, is clearly a strong fit with Sentinelle's guiding philosophies."

"These new coils help round out our offerings and allow us to provide a complete package for breast MR", said Bob Giegerich, director of MR Business Unit, Toshiba. "The Sentinelle coils' increased Signal to Noise when combined with Toshiba's low noise MR allows greatly improved visualization in breast MR images."

About Sentinelle Medical Inc.

Sentinelle Medical is dedicated to improving patient care with early detection and accurate intervention. The company researches, develops, manufactures, sells and supports leading edge Magnetic Resonance (MR) technologies. The ground breaking Sentinelle Vanguard(R) T-Series coil provides excellent quality MR images, complete and open access for intervention and award winning design that optimizes patient comfort and workflow. Sentinelle products are used in leading breast cancer sites throughout North America including Dartmouth-Hitchcock Medical Centre, H. Lee Moffitt Cancer Center and Research Institute (University of South Florida), Scripps Memorial Hospital, Sunnybrook Health Sciences Centre and University Health Network. Sentinelle Medical is a privately owned Canadian company.

For more information, visit www.sentinellemedical.com

About Toshiba

With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 198,000 employees worldwide and annual sales of $77 billion. For more information, visit www.medical.toshiba.com


'/>"/>
SOURCE Sentinelle Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology: